Understanding Factors that Influence Prognosis and Response to Therapy in Clear Cell Renal Cell Carcinoma

Adv Anat Pathol. 2024 Mar 1;31(2):96-104. doi: 10.1097/PAP.0000000000000428. Epub 2024 Jan 5.

Abstract

In this review, we highlight and contextualize emerging morphologic prognostic and predictive factors in renal cell carcinoma. We focus on clear cell renal cell carcinoma (ccRCC), the most common histologic subtype. Our understanding of the molecular characterization of ccRCC has dramatically improved in the last decade. Herein, we highlight how these discoveries have laid the foundation for new approaches to prognosis and therapeutic decision-making for patients with ccRCC. We explore the clinical relevance of common mutations, established gene expression signatures, intratumoral heterogeneity, sarcomatoid/rhabdoid morphology and PD-L1 expression, and discuss their impact on predicting response to therapy.

Publication types

  • Review

MeSH terms

  • B7-H1 Antigen
  • Carcinoma, Renal Cell* / genetics
  • Humans
  • Kidney Neoplasms* / pathology
  • Prognosis

Substances

  • B7-H1 Antigen